• Nenhum resultado encontrado

Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.

N/A
N/A
Protected

Academic year: 2017

Share "Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer."

Copied!
7
0
0

Texto

Loading

Imagem

Table 2. Survival days of patients.
Figure 3. Survival proportion for extensive stage patients with or without endobronchial mucosa invasion were traced with the Kaplan-Meier method (log rank test, p = 0.0005)
Table 3. Univariate analysis of factors potentially associated with survival time that is less than the median survival in SCLC a patients.
Table 4. Cox proportional hazard ratio analysis of SCLC a patients with a survival time less than the cohort median survival

Referências

Documentos relacionados

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern

Measurement of temperature: resistance thermometers VIII Objectives Basic concepts Experimental procedure Synthesis and acquired knowledge..

Como forma de contribuir para mudar a realidade e a preeminência masculina no mundo da ciência e tecnologia, são propostas ações por meio do projeto Meninas Digitais Tchê Missões com

The objective of the present article was to analyze the importance of social, behavioral, and clinical factors on the survival time of patients with non-small cell lung cancer

Criteria - Studies that statistically compare survival, disease-free survival, morbidity and mortality associated with the procedure, and mortality associated with cancer in

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

Overall survival for patients diagnosed with prostate (A), breast (B), colorectal (C) and lung cancer (D) according to stage in elderly patients diagnosed with solid tumors at